The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer.
about
Oscillatory dynamics of p38 activity with transcriptional and translational time delays.Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer.Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer.
P2860
The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Mitogen-Activated Protein ...... r Dasatinib in Thyroid Cancer.
@en
type
label
The Mitogen-Activated Protein ...... r Dasatinib in Thyroid Cancer.
@en
prefLabel
The Mitogen-Activated Protein ...... r Dasatinib in Thyroid Cancer.
@en
P2093
P2860
P1476
The Mitogen-Activated Protein ...... or Dasatinib in Thyroid Cancer
@en
P2093
Brittelle E Kessler
Guoliang Wang
Katie M Mishall
Kelsey E Wuensch
Maia L Corpuz
Qiong Zhou
Stephen M Riffert
Thomas C Beadnell
P2860
P304
P356
10.1158/1535-7163.MCT-15-0702
P577
2016-05-24T00:00:00Z